These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
890 related articles for article (PubMed ID: 110834)
21. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential. Greene KE; Kettel LM; Yen SS Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899 [TBL] [Abstract][Full Text] [Related]
22. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma. Spona J; Ulm R; Bieglmayer C; Husslein P Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775 [TBL] [Abstract][Full Text] [Related]
23. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle. Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214 [TBL] [Abstract][Full Text] [Related]
24. Action of tamoxifen on folliculogenesis in the menstrual cycle of infertile patients. Fukushima T; Maeyama M Fertil Steril; 1983 Aug; 40(2):210-4. PubMed ID: 6409673 [TBL] [Abstract][Full Text] [Related]
25. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women. Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914 [TBL] [Abstract][Full Text] [Related]
26. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach. Lemay A; Faure N J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711 [TBL] [Abstract][Full Text] [Related]
27. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception. Balogh A; Ditrói F; Lampé LG Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699 [TBL] [Abstract][Full Text] [Related]
28. Reduction in pituitary desensitization and prolongation of gonadotropin release by estrogen during continuous administration of gonadotropin-releasing hormone in women: its antagonism by progesterone. Araki S; Chikazawa K; Motoyama M; Ijima K; Abe N; Tamada T J Clin Endocrinol Metab; 1985 Mar; 60(3):590-8. PubMed ID: 3919050 [TBL] [Abstract][Full Text] [Related]
29. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women. Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322 [TBL] [Abstract][Full Text] [Related]
30. On the correlation of luteinizing hormone-releasing hormone, luteinizing hormone, follicle-stimulating hormone, and prolactin levels in plasma of women with normal menstrual cycles. Aksel S Am J Obstet Gynecol; 1981 Oct; 141(4):362-7. PubMed ID: 6792924 [TBL] [Abstract][Full Text] [Related]
31. Acute effects of progesterone and the antiprogestin RU 486 on gonadotropin secretion in the follicular phase of the menstrual cycle. Permezel JM; Lenton EA; Roberts I; Cooke ID J Clin Endocrinol Metab; 1989 May; 68(5):960-5. PubMed ID: 2497130 [TBL] [Abstract][Full Text] [Related]
32. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state. de Kretser DM; Burger HG; Dumpys R J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423 [TBL] [Abstract][Full Text] [Related]
33. Hypersensitivity of the human gonadotrophs to the repeated administration of small doses of LH-RH. Faure N; Olivier GC Horm Res; 1978; 9(1):12-21. PubMed ID: 338460 [TBL] [Abstract][Full Text] [Related]
34. Decreased follicular phase gonadotropin secretion is associated with impaired estradiol and progesterone secretion during the follicular and luteal phases in normally menstruating women. Schweiger U; Laessle RG; Tuschl RJ; Broocks A; Krusche T; Pirke KM J Clin Endocrinol Metab; 1989 May; 68(5):888-92. PubMed ID: 2497129 [TBL] [Abstract][Full Text] [Related]
35. Endocrine pathophysiology of luteal phase deficiency as assessed by GnRH/TRH stimulation tests performed in the early follicular and midluteal phases of the menstrual cycle. Hayashi M; Suginami H; Taii S; Mori T Endocr J; 1993 Jun; 40(3):297-309. PubMed ID: 7920882 [TBL] [Abstract][Full Text] [Related]
36. The functional changes of the pituitary gonadotrophs during the menstrual cycle. Wang CF; Lasley BL; Lein A; Yen SS J Clin Endocrinol Metab; 1976 Apr; 42(4):718-28. PubMed ID: 770496 [TBL] [Abstract][Full Text] [Related]
37. Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women. Groom GV; Griffiths K J Endocrinol; 1976 Sep; 70(3):421-8. PubMed ID: 978103 [TBL] [Abstract][Full Text] [Related]
38. Cimetidine and plasma levels of gonadotropins, prolactin and gonadal steroids in women. Bélisle S; Patry M; Tétreault L Can Med Assoc J; 1982 Jul; 127(1):29-32. PubMed ID: 6805933 [TBL] [Abstract][Full Text] [Related]
39. Effect of luteal metoclopramide-induced hyperprolactinemia on pituitary and luteal responsiveness to gonadotropin-releasing hormone. Caruso A; Lanzone A; Fulghesu AM; Apa R; Guida C; Mancuso S Horm Res; 1989; 31(4):169-74. PubMed ID: 2507435 [TBL] [Abstract][Full Text] [Related]
40. Tamoxifen in the treatment of infertility associated with luteal phase deficiency. Fukushima T; Tajima C; Fukuma K; Maeyama M Fertil Steril; 1982 Jun; 37(6):755-61. PubMed ID: 6806128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]